Protective and Anti-Pathology Effects of Sm Fructose-1,6-Bisphosphate Aldolase-Based DNA Vaccine against Schistosoma mansoni by Changing Route of Injection |
Saber, Mohamed
(Biochemistry Department, Theodor Bilharz Research Institute)
Diab, Tarek (Parasitology Department, Theodor Bilharz Research Institute) Hammam, Olft (Pathology Department, Theodor Bilharz Research Institute) Karim, Amr (Biochemistry Department, Faculty of Science, Ain Shams University) Medhat, Amina (Biochemistry Department, Faculty of Science, Ain Shams University) Khela, Mamdouh (Biochemistry Department, Theodor Bilharz Research Institute) El-Dabaa, Ehab (Biochemistry Department, Theodor Bilharz Research Institute) |
1 | Wei F, Liu Q, Zhai Y, Fu Z, Liu W, Shang L, Men J, Gao S, Lian H, Jin H, Chen C, Lin J, Shi Y, Xia Z, Zhu XQ. IL-18 enhances protective effect in mice immunized with a Schistosoma japonicum FABP DNA vaccine. Acta Trop 2009; 3: 284-288. |
2 | Zhu Y, Lu F, Dai Y, Wang X, Tang J, Zhao S, Zhang C, Zhang H, Lu S, Wang S. Synergistic enhancement of immunogenicity and protection in mice against Schistosoma japonicum with codon optimization and electroporation delivery of SjTPI DNA vaccines. Vaccine 2010; 28: 5347-5355. DOI ScienceOn |
3 | Romeih MH, Hassan HM, Shousha TS, Saber MA. Immunization against Egyptian Schistosoma mansoni infection by multivalent DNA vaccine. Acta Biochim Biophys Sin (Shanghai) 2008; 40: 327-338. DOI ScienceOn |
4 | Nessim N, Hassan S, William S, el-Baz H. Effect of the broad spectrum antihelmintic drug flubendazole upon Schistosoma mansoni experimentally infected mice. Arzneimittelforschung 2000; 50: 1129-1113. |
5 | Innis MA, Gelfand DH, Sninsky JJ, White TJ. PCR Protocols. A Guide to Methods and Applications. San Diego, California, USA. Academic Press. 1990; p 4-36. |
6 | Shuman S. Novel approach to molecular cloning and polynucleotide synthesis using vaccinia DNA topoisomerase. J Biol Chem 1994; 269: 32678-32684. |
7 | Sambrook J, Russell DW. Molecular Cloning: A Laboratory Manual. 3rd ed. N Y., USA. Cold Spring Harbor Laboratory Press. 2001. |
8 | Kamel I, Cheever A, Elwi A, Mosimann JE, Danner R. Schistosoma mansoni and Schistosoma haematobium infections in Egypt. I. Evaluation of techniques for recovery of worms and eggs at necropsy. Am J Trop Med Hyg 1977; 26: 696-701. |
9 | Shalaby KA, Yin L, Thakur A, Christen L, Niles EG, LoVerde PT. Protection against Schistosoma mansoni utilizing DNA vaccination with genes encoding Cu/Zn cytosolic superoxide dismutase, signal peptide-containing superoxide dismutase and glutathione peroxidase enzymes. Vaccine 2003; 22: 130-136. DOI ScienceOn |
10 | Hillyer GV, Gomez de Rios I. The enzyme-linked immunosorbent assay (ELISA) for the immunodiagnosis of schistosomiasis. Am J Trop Med Hyg 1979; 28: 237-241. |
11 | Duvall R, DeWitt W. An improved perfusion technique for recovering adult schistosomes from laboratory animals. Am J Trop Med Hyg 1967; 6: 483-486. |
12 | Pellegrino J, Oliveira CA, Faria J. New approach to the screening of drugs in experimental schistosomiasis mansoni in mice. Am J Trop Med Hyg 1962; 11: 201-215. |
13 | von Lichtenberg FC. Host response to eggs of Schistosoma mansoni. I. Granuloma formation in the sensitized laboratory mouse. Am J Pathol 1962; 41: 711-731. |
14 | Coban C, Kobiyama K, Aoshi T, Takeshita F, Horii T, Akira S, Ishii KJ. Novel strategies to improve DNA vaccine immunogenicity. Curr Gene Ther 2011; 11: 479-484. DOI |
15 | Kozak M. An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res 1987; 15: 8125-8148. DOI ScienceOn |
16 | Cherif MS, Shuaibu MN, Kurosaki T. Immunogenicity of novel nanoparticle-coated MSP-1 C-terminus malaria DNA vaccine using different routes of administration. Vaccine 2011; 29: 9038-9050. DOI ScienceOn |
17 | Wynn TA, Cheever AW, Jankovic D, Poindexter RW, Caspar P, Lewis FA, Sher A. An IL-12 based vaccination method for preventing fibrosis induced by schistosome infection. Nature 1995; 376: 594-596. DOI ScienceOn |
18 |
Kedzierska K, Curtis JM, Valkenburg SA, Hatton LA, Kiu H, Doherty PC, Kedzierski L. Induction of protective |
19 | Lundstrom K. Alphavirus-based vaccines. Curr Opin Mol Ther 2002; 4: 28-34. |
20 | Zhu Y, Ren J, Da'dara A, Harn D, Xu, M, Si J, Yu C, Liang Y, Ye P, Yin X, He W, Xu Y, Cao G, Hua W. The protective effect of a Schistosoma japonicum Chinese strain 23 kDa plasmid DNA vaccine in pigs is enhanced with IL-12. Vaccine 2004; 23: 78-83. DOI ScienceOn |
21 | Hoffmann KF, Caspar P, Cheever AW, Wynn TA. INF-gamma, IL-12 and TNF-alpha are required to maintain reduced liver pathology in mice vaccinated with Schistosoma mansoni eggs and IL-12. J Immunol 1998; 161: 4201-4210. |
22 | Pearce EJ, Vasconcelos JP, Brunet LR, Sabin EA. IL-4 in schistosomiasis. Exp Parasitol 1996; 84: 295-299. DOI ScienceOn |
23 | Eberl M, Beck E, Coulson CP, Okamura H, Wilson WR, Mountford MA. IL-18 potentiates the adjuvant properties of IL-12 in the induction of a strong Th1 type immune response against a recombinant antigen. Vaccine 2000; 18: 2002-2008. DOI ScienceOn |
24 | Skelly PJ, Stein LD, Shoemaker CB. Expression of Schistosoma mansoni genes involved in anaerobic and oxidative glucose metabolism during the cercariae to adult transformation. Molecular Biochem Parasitol 1993; 60: 93-104. DOI ScienceOn |
25 | El-Khoby T, Galal N, Fenwick A, Barakat R, El-Hawey A, Nooman Z, Habib M, Abdel-Wahab F, Gaber NS, Hammom HM, Hussein MH, Mikhail NN, Cline BL, Srrickland GT. The epidemiology of schistosomiasis in Egypt: summary findings in nine governorates. Am J Trop Med Hyg 2000; 62: 88-99. |
26 | McManus DP, Loukas A. Current status of vaccines for schistosomiasis. Clin Microbiol Rev 2008; 21: 225-242. DOI ScienceOn |
27 | Mathews CK, Van Hold KE. Biochemistry. Redwood City, California, USA. The Bengamin/Cumming Publishing Company, Inc. 1990, p 433-455. |
28 | Richter D, Reynolds SR, Harn DA. Candidate vaccine antigens that stimulate the cellular immune response of mice vaccinated with irradiated cercariae of Schistosoma mansoni. J Immunol 1993; 151: 256-265. |
29 | El-Dabaa E, Mei H, El-Sayed A, Karim AM, Eldesoky HM, Fahim FA, LoVerde PT, Saber MA. Cloning and characterization of Schistosoma mansoni fructose-1,6-bisphosphate aldolase isozyme. J Parasitol 1998; 84: 954-960. DOI ScienceOn |
30 | Rumjanek FK. Biochemistry and physiology. In Rollinson D, AJG Simpson AJG eds, The Biology of Schistosomes. London, UK. Academic Press. 1987, p 163-183. |
31 | Harrop R, Coulson PS, Wilson RA. Characterization, cloning and immunogenicity of antigens released by lung-stage larvae of Schistosoma msnoni. Parasitology 1999; 118: 583-594. DOI ScienceOn |
32 | Marques HH, Zouain CS, Torres CBB, Oliveira JS, Alvesb JB, Goes AM. Protective effect and granuloma down-modulation promoted by RP44 antigen a fructose 1,6 bisphosphate aldolase of Schistosoma mansoni. Immunobiology 2008; 213: 437-446. DOI ScienceOn |
33 | Capron A, Riveau GJ, Bartley PB, McManus DP. Prospects for a schistosome vaccine. Curr Drug Targets Immune Endocr Metabol Disord 2002; 2: 281-290. DOI ScienceOn |
34 | Ahmed H, Romeih M, Abou Shousha T. DNA Immunization with the gene encoding Sm21.7 protein protects mice against Schistosoma mansoni infections. J Am Sci 2006; 2: 59-69. |
35 | Melkebeek V, Sonck E, Verdonck F, Goddeeris BM, Cox E. Optimized FaeG expression and a thermolabile enterotoxin DNA adjuvant enhance priming of an intestinal immune response by an FaeG DNA vaccine in pigs. Clin Vaccine Immunol 2007; 14: 28-35. DOI ScienceOn |
![]() |